Five-year risk of CIN3+ and cervical cancer for women who test Pap-negative, but are HPV-positive

Схожие документы

• Five-year risks of CIN2+ and CIN3+ for women with HPV-positive and HPV-negative LSIL Pap results
  по: Katki, Hormuzd A., et al.
  Опубликовано: (2013)
• Five-year risk of recurrence following treatment of CIN2, CIN3, or AIS: performance of HPV and Pap cotesting in post-treatment management
  по: Katki, Hormuzd A., et al.
  Опубликовано: (2013)
• Five-year risk of CIN3+ and cervical cancer for women with HPV testing of ASC-US Pap results
  по: Katki, Hormuzd A., et al.
  Опубликовано: (2013)
• Five-year risk of CIN3+ and cervical cancer for women with HPV-positive and HPV-negative high-grade Pap results
  по: Katki, Hormuzd A., et al.
  Опубликовано: (2013)
• Benchmarking CIN3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines
  по: Katki, Hormuzd A., et al.
  Опубликовано: (2013)